NASDAQ : COYA
Coya Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 3.61 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 84.68M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Coya Therapeutics, Inc. (COYA) reported revenue of 8.02M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 8.02M | 7.95M | 3.55M | 6.00M | ||
| Cost of Revenue | 16.98M | 16.73M | 11.87M | 5.50M | 4.41M | |
| Gross Profit | -8.97M | -8.79M | -8.31M | 500.68K | -4.41M | |
| Selling, General & Admin | 11.86M | 11.45M | 8.89M | 7.83M | 4.85M | 2.31M |
| Research & Development | 2.54M | |||||
| Operating Expenses | 11.88M | 11.48M | 8.91M | 7.86M | 4.87M | 4.87M |
| Operating Income | -20.85M | -20.27M | -17.22M | -7.36M | -9.29M | -4.87M |
| Interest & Investment Income | 1.48M | 1.33M | 1.65M | 639.37K | ||
| Other Non Operating Income (Expenses) | -2.43M | -21.48K | ||||
| EBT Excluding Unusual Items | -19.37M | -18.93M | -15.58M | -6.72M | -11.72M | -4.89M |
| Pretax Income | -21.67M | -21.22M | -15.60M | -7.26M | -12.24M | -4.89M |
| Income Tax Expense | 3.09K | 3.09K | -720.29K | 723.85K | ||
| Net Income | -21.67M | -21.23M | -14.88M | -7.99M | -12.24M | -4.89M |
| Net Income to Common | -21.67M | -21.23M | -14.88M | -7.99M | -12.24M | -4.89M |
| Shares Outstanding (Basic) | 19.90M | 16.73M | 15.24M | 10.16M | 2.59M | 2.59M |
| Shares Outstanding (Diluted) | 19.90M | 16.73M | 15.24M | 10.16M | 2.59M | 2.59M |
| EPS (Basic) | -1.09 | -1.27 | -0.98 | -0.79 | -4.73 | -1.89 |
| EPS (Diluted) | -1.09 | -1.27 | -0.98 | -0.79 | -4.73 | -1.89 |
| Free Cash Flow | -15.72M | -10.74M | -10.29M | -11.19M | -7.24M | -4.04M |
| Free Cash Flow Per Share | -0.79 | -0.64 | -0.68 | -1.10 | -2.79 | -1.56 |
| Gross Margin | -111.80% | -110.61% | -233.86% | 8.34% | ||
| Operating Margin | -260.00% | -255.05% | -484.65% | -122.62% | ||
| Profit Margin | -270.22% | -267.14% | -418.70% | -133.08% | ||
| Free Cash Flow Margin | -196.06% | -135.16% | -289.50% | -186.41% | ||
| EBITDA | -20.83M | -20.24M | -17.20M | -7.33M | -9.26M | -4.85M |
| EBITDA Margin | -259.76% | -254.71% | -122.17% | |||
| D&A For EBITDA | 19.30K | 27.36K | 27.36K | 27.36K | 27.36K | 16.13K |
| EBIT | -20.85M | -20.27M | -17.22M | -7.36M | -9.29M | -4.87M |
| EBIT Margin | -260.00% | -255.05% | -122.62% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 43.18M | 46.82M | 38.34M | 32.63M | 5.93M | 4.34M |
| Cash & Short-Term Investments | 43.18M | 46.82M | 38.34M | 32.63M | 5.93M | 4.34M |
| Other Receivables | 730.58K | 7.50M | ||||
| Receivables | 730.58K | 7.50M | ||||
| Prepaid Expenses | 3.88M | 3.12M | 5.24M | 1.07M | 1.25M | 244.08K |
| Total Current Assets | 47.06M | 49.94M | 44.31M | 41.20M | 7.18M | 4.58M |
| Property, Plant & Equipment | 5.61K | 11.23K | 38.59K | 65.95K | 93.31K | 120.67K |
| Long-Term Deferred Charges | 1.12M | 87.18K | ||||
| Total Assets | 47.31M | 49.95M | 44.35M | 41.26M | 8.40M | 4.79M |
| Accounts Payable | 1.09M | 1.06M | 1.59M | 1.16M | 1.82M | 857.57K |
| Accrued Expenses | 1.19M | 3.61M | 1.39M | 2.25M | 2.01M | 290.82K |
| Current Income Taxes Payable | 723.85K | |||||
| Current Unearned Revenue | 1.23M | 1.20M | 848.29K | 923.11K | ||
| Total Current Liabilities | 3.51M | 5.87M | 3.82M | 5.05M | 3.82M | 1.15M |
| Long-Term Debt | 12.97M | |||||
| Long-Term Unearned Revenue | 519.64K | 1.05M | 945.45K | 574.68K | ||
| Total Liabilities | 4.03M | 6.92M | 4.77M | 5.63M | 16.79M | 1.15M |
| Common Stock | 2.35K | 2.09K | 1.67K | 1.44K | 259.00 | 259.00 |
| Additional Paid-In Capital | 119.08M | 104.99M | 80.31M | 61.50M | 681.11K | 473.60K |
| Retained Earnings | -75.81M | -61.96M | -40.74M | -25.86M | -17.87M | -5.62M |
| Comprehensive Income & Other | -11.25K | |||||
| Total Common Equity | 43.28M | 43.03M | 39.58M | 35.64M | -17.19M | -5.15M |
| Shareholders' Equity | 43.28M | 43.03M | 39.58M | 35.64M | -8.39M | 3.64M |
| Total Liabilities & Equity | 47.31M | 49.95M | 44.35M | 41.26M | 8.40M | 4.79M |
| Total Debt | 12.97M | |||||
| Net Cash (Debt) | 43.18M | 46.82M | 38.34M | 32.63M | -7.03M | 4.34M |
| Net Cash Per Share | 2.17 | 2.80 | 2.52 | 3.21 | -2.71 | 1.68 |
| Filing Date Shares Outstanding | 23.46M | 23.46M | 16.72M | 14.54M | 9.95M | 2.59M |
| Total Common Shares Outstanding | 23.46M | 20.93M | 16.71M | 14.41M | 2.59M | 2.59M |
| Working Capital | 43.55M | 44.07M | 40.48M | 36.14M | 3.36M | 3.44M |
| Book Value Per Share | 1.84 | 2.06 | 2.37 | 2.47 | -6.64 | -1.99 |
| Tangible Book Value | 43.28M | 43.03M | 39.58M | 35.64M | -17.19M | -5.15M |
| Tangible Book Value Per Share | 1.84 | 2.06 | 2.37 | 2.47 | -6.64 | -1.99 |
| Machinery | 136.80K | 136.80K | 136.80K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -21.67M | -21.23M | -14.88M | -7.99M | -12.24M | -4.89M |
| Depreciation & Amortization | 19.30K | 27.36K | 27.36K | 27.36K | 27.36K | 16.13K |
| Other Amortization | 997.37K | |||||
| Asset Writedown & Restructuring Costs | 2.30M | 2.29M | 25.00K | 543.19K | 525.00K | |
| Stock-Based Compensation | 5.31M | 4.29M | 2.66M | 872.25K | 207.35K | 233.22K |
| Other Operating Activities | 2.50M | |||||
| Change in Accounts Payable | 33.73K | -527.01K | 477.45K | 298.82K | 845.28K | 665.17K |
| Change in Unearned Revenue | 380.86K | 454.25K | 295.94K | 1.50M | ||
| Change in Other Net Operating Assets | -2.10M | 3.95M | 1.10M | -6.44M | -93.45K | 74.00K |
| Operating Cash Flow | -15.72M | -10.74M | -10.29M | -11.19M | -7.24M | -3.90M |
| Capital Expenditures | -136.80K | |||||
| Sale (Purchase) of Intangibles | -2.05M | -1.16M | -25.00K | -543.19K | -525.00K | |
| Investing Cash Flow | -2.05M | -1.16M | -25.00K | -543.19K | -525.00K | -136.80K |
| Long-Term Debt Issued | 10.47M | |||||
| Total Debt Issued | 10.47M | |||||
| Net Debt Issued (Repaid) | 10.47M | |||||
| Issuance of Common Stock | 31.32M | 20.39M | 16.16M | 38.43M | 158.00 | 1.32K |
| Other Financing Activities | -124.29K | -131.92K | -1.11M | -341.90K | ||
| Financing Cash Flow | 31.20M | 20.39M | 16.03M | 38.43M | 9.36M | -340.58K |
| Net Cash Flow | 13.42M | 8.48M | 5.71M | 26.69M | 1.59M | -4.38M |
| Free Cash Flow | -15.72M | -10.74M | -10.29M | -11.19M | -7.24M | -4.04M |
| Free Cash Flow Margin | -196.06% | -135.16% | -289.50% | -186.41% | ||
| Free Cash Flow Per Share | -0.79 | -0.64 | -0.68 | -1.10 | -2.79 | -1.56 |
| Levered Free Cash Flow | -10.94M | -4.61M | -6.73M | -10.33M | -3.43M | -2.45M |
| Unlevered Free Cash Flow | -10.94M | -4.61M | -6.73M | -10.33M | -4.43M | -2.45M |
| Change in Working Capital | -1.69M | 3.88M | 1.88M | -4.64M | 751.84K | 739.17K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 84.68M | 121.36M | 95.73M | 106.71M | 12.27M | |
| Enterprise Value | 41.50M | 93.23M | 64.68M | 95.82M | 24.26M | |
| Last Close Price | 3.61 | 5.80 | 5.73 | 7.41 | 4.74 | |
| PS Ratio | 10.56 | 15.27 | 26.94 | 17.78 | ||
| PB Ratio | 1.96 | 2.82 | 2.42 | 2.99 | -1.46 | |
| P/TBV Ratio | 1.96 | 2.82 | 2.42 | 2.99 | ||
| EV/Sales Ratio | 5.18 | 11.73 | 18.20 | 15.96 | ||
| Debt / Equity Ratio | -1.54 | |||||
| Net Debt / Equity Ratio | -1.00 | -1.09 | -0.97 | -0.92 | -0.84 | -1.19 |
| Net Debt / EBITDA Ratio | 2.07 | 2.31 | 2.23 | 4.45 | -0.76 | 0.89 |
| Net Debt / FCF Ratio | 2.75 | 4.36 | 3.73 | 2.92 | -0.97 | 1.07 |
| Asset Turnover | 0.20 | 0.17 | 0.08 | 0.24 | ||
| Quick Ratio | 12.29 | 7.97 | 10.22 | 7.94 | 1.55 | 3.78 |
| Current Ratio | 13.40 | 8.51 | 11.59 | 8.15 | 1.88 | 3.99 |
| Return on Equity (ROE) | -60.54% | -51.39% | -39.57% | -58.64% | -81.90% | |
| Return on Assets (ROA) | -32.27% | -26.86% | -25.15% | -18.53% | -88.03% | -44.96% |
| Return on Capital Employed (ROCE) | -47.60% | -46.00% | -42.50% | -20.30% | -203.10% | -133.70% |
| Earnings Yield | -30.17% | -17.49% | -15.54% | -7.49% | -99.77% | |
| FCF Yield | -18.57% | -8.85% | -10.75% | -10.48% | -58.99% | |
| Buyback Yield / Dilution | -22.38% | -9.79% | -49.93% | -292.40% | -0.01% | -40.88% |